OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Liver Disease is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma	85
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD	42
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns	35
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?	34
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype	33
Genetic and Epigenetic Basis of Drug-Induced Liver Injury	29
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease	28
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease	27
HBV Biomarkers and Their Role in Guiding Treatment Decisions	27
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis	23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy	21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies	20
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury	19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver	18
Role of YAP1 Signaling in Biliary Development, Repair, and Disease	17
Wilson Disease: Novel Diagnostic and Therapeutic Approaches	16
Mice Engrafted with Human Liver Cells	16
Diagnosis and Management of Early Stages of ALD	15
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective	15
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination	14
Circadian Regulation of Gene Expression and Metabolism in the Liver	14
	11
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure	11
	10
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases	10

	10
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure	10
Role of Complement in Liver Diseases	10
Liver Neurobiology: Regulation of Liver Functions by the Nervous System	10
Management of Portal vein Thrombosis in Cirrhosis	9
Mesenchymal Stem Cell Transplantation in Liver Diseases	9
Novel Biomarkers of AKI in Cirrhosis	9
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol	9
Endoscopic Advances in Hepatology	9
Patient-Centered Treatment of Cirrhosis	9
Combined Hepatocellular-Cholangiocarcinoma: A Clinical and Molecular Review	9
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future	9
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy	8
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease	8
Extracellular Vesicles and Micro-RNAs in Liver Disease	8
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology	8
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency	8
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology	8
Hepatocellular Carcinoma Chemoprevention with Generic Agents	8
Hepatitis Delta Infection: A Clinical Review	8
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease	8